Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid...

Area of Science:

• Ophthalmology
• Inflammatory eye disease research

Background:

• Intermediate, posterior, and panuveitis are serious ocular conditions.
• Understanding factors influencing visual acuity is crucial for patient management.

Purpose of the Study:

• To identify factors associated with baseline best-corrected visual acuity (BCVA) and its 2-year outcome.
• To analyze predictors of visual acuity presentation and change in 479 eyes with intermediate, posterior, and panuveitis.

Main Methods:

• A cohort study utilizing data from the Multicenter Uveitis Steroid Treatment (MUST) Trial.
• Analysis of masked BCVA measurements at baseline and 2-year follow-up across 23 clinical centers.
• Evaluation of clinical characteristics as potential predictive factors for BCVA.

Main Results:

• Baseline factors associated with reduced BCVA included older age, posterior uveitis, longer uveitis duration, anterior chamber flare, cataract, macular thickening, and exudative retinal detachment.
• Eyes with BCVA of 20/50 or worse at baseline showed significant improvement (10 letters) over 2 years.
• Factors linked to improved BCVA were resolution of inflammation and cataract surgery; worsening was associated with prolonged inflammation, cataract, and vitreous haze.

Conclusions:

• Intermediate, posterior, and panuveitis generally have a favorable prognosis with current treatments.
• Prolonged or severe inflammation negatively impacts visual acuity prognosis.
• Effective management of ocular inflammation is vital for preserving visual acuity.